最新ニュース Revolve Gr (NYSE:RVLV) 株価情報

Revolve Gr

The Revolve Group is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2023 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the US, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 20% of sales from private-label offerings, while focusing on building an inventory of unique products from emerging fashion brands with less than $10 million in annual sales.

Revolve Group Inc

Barclays analyst Adrienne Yih maintains Bath &amp; Body Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) with a Underweight and raises the price target from $28 to $34.

News

Price Target

Analyst Ratings

BBWI

Barclays Maintains Underweight on Bath & Body Works, Raises Price Target to $34

Truist Securities analyst Patrick Scholes maintains Travel+Leisure (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNL#NYSE">TNL</a>) with a Buy and raises the price target from $60 to $61.

Truist Securities Maintains Buy on Travel+Leisure, Raises Price Target to $61

Milestone Scientific Inc. (NYSE:<a href="https://www.benzinga.com/stock/MLSS#NYSE">MLSS</a>), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced its approval on contract for the Federal Supply Schedule (FSS), also known as the GSA Schedule, for the CompuFlo&#xAE; Epidural System. This significant milestone follows the Company's earlier registration with the U.S. Government's System for Award Management (SAM) in March 2023.
The FSS designation positions Milestone Scientific as a pre-vetted contractor with pre-negotiated pricing for its CompuFlo&#xAE; Epidural System and related consumable products. FSS contracts are initially awarded to sell products and services to the government for a five-year base period and can be extended through three additional five-year option periods, allowing for a potential total contract duration of up to 20 years. This streamlined procurement process allows federal agencies to save time and money while securing Milestone Scientific's innovative technologies.
The CompuFlo&#xAE; Epidural System utilizes Milestone Scientific's patented Dynamic Pressure Sensing Technology&#xAE;, offering real-time feedback to ensure accurate needle placement during epidural procedures. This innovation enhances patient safety and comfort, reducing the risk of complications associated with traditional techniques.
The inclusion of Milestone Scientific on the FSS opens significant opportunities within federal healthcare systems, including the Department of Defense (DoD), the Department of Veterans Affairs (VA), and the Indian Health Service (IHS):
<ul>
<li>Veterans Health Administration (VHA): The VHA is the largest integrated healthcare system in the United States, providing care at 1,380 facilities, including 170 VA Medical Centers and 1,193 outpatient sites. About one-third of the 9.1 million veterans enrolled in the VHA experience chronic pain, a higher prevalence than in the general population. &nbsp;</li>
<li>Department of Defense (DoD): The Military Health System (MHS) serves approximately 9.5 million beneficiaries, including active-duty service members, retirees, and their families, through 45 hospitals, 572 clinics, and 115 dental clinics. According to a RAND study, between 31% and 44% of active-duty U.S. service members experience chronic pain, highlighting a significant burden within the DoD population. Chronic pain is considered a leading cause of disability and reduced readiness among service members, making effective pain management solutions a critical need for the DoD. 
<ul>
<li>Indian Health Service (IHS): The IHS provides healthcare to 2.8 million American Indians and Alaska Natives across the United States through over 687 facilities, including hospitals, health centers, health stations, and school health centers. Approximately 19.3% of individuals utilizing IHS facilities experience chronic pain, with prevalence rates notably higher among women and older adults. &nbsp;</li>
</ul>
</li>
</ul>

MLSS

Milestone Scientific Secures Federal Supply Schedule Approval On Contract For CompuFlo Epidural System

Intelligent Fingerprinting Drug Screening System on path to FDA 510(k) submission, expected in the fourth calendar quarter of 2024
INBS will include data from recent PK study alongside results of method comparison study in 510(k) submission

Biotech

General

Intelligent Bio Solutions Inc. - Common Stock

INBS

Intelligent Bio Solutions Completes  Method Comparison Study On Its Intelligent Fingerprinting Drug Screening System

STK Steakhouse brings its unrivaled VIBE dining experience to Canada, overlooking Niagara Falls
This location is the 30th STK Steakhouse in operation; the new, licensed location is part of the Company's asset light growth strategy
The ONE Group Hospitality, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) today announced the recent opening of the newest <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fstksteakhouse.com%2F&amp;esheet=54158249&amp;newsitemid=20241126821548&amp;lan=en-US&amp;anchor=STK+Steakhouse&amp;index=1&amp;md5=88a8fc4bbddacd592e33537cb14b7a88">STK Steakhouse</a> with beautiful views of Niagara Falls, on the Canadian side. Located at 6700 Fallsview Blvd., the new restaurant offers VIBE dining at its finest with incredible views and is situated within the Embassy Suites Hotel. The location offers elevated culinary curations, world-famous cocktails and live music spun by renowned DJs. The opening of STK Niagara Falls offers a new location for locals and tourists alike for sought-after views and an upscale dining experience.

Global

STKS

The ONE Group Hospitality, Inc. Opens New STK Niagara Falls Location;  Location Is The 30th STK Steakhouse In Operation; The New, Licensed Location Is Part Of The Co's Asset Light Growth Strategy

On Tuesday, Amgen&nbsp;Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) stock fell during the premarket session after the company released long-anticipated data from the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133) <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42185604/amgen-announces-robust-weight-loss-with-maritide-in-people-living-with-obesity-or-overweight-at-52" rel="noreferrer noopener">in obese patients</a>.
The company said that MariTide demonstrated up to ~20% average weight loss at one year (52 weeks) without a weight loss plateau, indicating the potential for further weight loss beyond 52 weeks.
Amgen&#8217;s stock dropped as the results seemed to fall short of Wall Street&#8217;s high expectations. CNBC noted that analysts had hoped MariTide would achieve at least 20% weight loss in the Phase 2 trial, with some <a target="_blank" href="https://www.cnbc.com/2024/11/26/amgen-says-weight-loss-drug-maritide-caused-up-to-20percent-weight-loss-after-a-year.html" rel="noreferrer noopener">aiming</a> for as much as 25%.
The study also showed that a subset of patients who typically lose less weight on GLP-1 therapies achieved up to ~17% average weight loss without a weight loss plateau, lowering their average hemoglobin A1C (HbA1c) by up to 2.2 percentage points at week 52.
MariTide also demonstrated improvements in cardiometabolic parameters, including blood pressure, triglycerides, and high-sensitivity C-reactive protein (hs-CRP) across doses. There were no significant increases in free fatty acids.
There was no association between the administration of MariTide and bone mineral density changes.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41950871/amgen-defends-its-investigational-monthly-weight-loss-injection-after-analyst-cites-maritides-impact-on-bone-density" rel="noreferrer noopener">Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide&#8217;s Impact on Bone Density</a>
The most common side effects were gastrointestinal, including vomiting, nausea, and constipation. Amgen said the discontinuation rate in the dose escalation arms due to any AE was ~11% and less than 8% for GI-related events. No additional safety signals were identified.
In a separate ongoing Phase 1 pharmacokinetic study, additional dosing regimens have been evaluated in a planned preliminary analysis.
The ongoing Part 2 of the Phase 2 study is investigating MariTide beyond 52 weeks to evaluate further weight loss with continued treatment, weight maintenance through less frequent or lower dosing and durability of weight loss after discontinuation of MariTide.
MariTide is expected to be delivered as a single dose in a handheld, autoinjector device with a monthly or less frequent single-injection administration.
Amgen is also advancing its obesity pipeline, including oral and injectable approaches composed of incretin and non-incretin mechanisms.
Price Action: AMGN stock is down 11.6% at $259.88 during the premarket session at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/42188320/best-buy-says-q3-sales-little-softer-than-expected-on-lower-demand-for-appliances-and-gaming-trims-annual-forecast" target="_blank" rel="noreferrer noopener">Best Buy Says Q3 Sales &#8216;Little Softer Than Expected&#8217; On Lower Demand For Appliances And Gaming, Trims Annual Forecast</a></li>
</ul>
Photo via Shutterstock.

Equities

Large Cap

Health Care

Movers

Trading Ideas

AMGN

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

WIIM

M&T Bank shares are trading lower. The stock may be moving on continued weakness following a Citigroup ratings downgrade from Buy to Neutral on Monday.

Truist Securities analyst Patrick Scholes maintains Marriott Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAC#NYSE">VAC</a>) with a Buy and raises the price target from $139 to $142.

Truist Securities Maintains Buy on Marriott Vacations, Raises Price Target to $142

FDA Marketing Authorization Decision on Early Stage-Low Risk Breast Cancer Expected in Q1 2025
Conference call to be held today at 10:00 am Eastern Time
CAESAREA, Israel, Nov. 26, 2024 /PRNewswire/ -- <a href="https://icecure-medical.com/">IceCure Medical Ltd.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCM#NASDAQ">ICCM</a>) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today reported financial results as of and for the nine months ended September 30, 2024. Sales of ProSense&#xAE; consoles and disposable probes increased by 36%. Gross profits increased by 41%, while non-GAAP gross profits grew by 104%. Gross margins increased to 43%, while non-GAAP gross margin increased to 40%, compared to 27% in the same period in 2023].

ICCM

IceCure Medical Reports 36% Sales Growth In The First 9-Months Of 2024 Driven By Global Adoption Of ProSense Cryoablation; FDA Marketing Authorization Decision On Early Stage-Low Risk Breast Cancer Expected In Q1 2025

Legal

NCPL

Netcapital's Netcapital Securities Subsidiary Receives Approval To Become A FINRA-Member Broker-Dealer

BTC Digital Ltd. ("BTCT"or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCT#NASDAQ">BTCT</a>), a global leader in Bitcoin (BTC) mining, announced today that it is actively seeking business opportunities in Arkansas, Tennessee, Georgia, and Missouri to further expand the scale and number of its mining facilities. This initiative aims to meet the growing computational power demands of both the company and the market while fulfilling its strategic commitment to sustainability.
BTCT is exploring various approaches, including building new facilities, acquiring existing mines, and forming strategic joint ventures with local businesses or institutions, to achieve a stable, long-term, and sustainable energy supply. The Company expects that these measures will not only strengthen BTCT's market position in the Bitcoin mining sector but also help the Company build a forward-looking and competitive computational power ecosystem.

BTCT

BTCT  Announces It Is Actively Seeking Business Opportunities In Arkansas, Tennessee, Georgia, And Missouri To Further Expand The Scale And Number Of Its Mining Facilities; Initiative Aims To Meet The Growing Computational Power Demands Of Both The Company And The Market While Fulfilling Its Strategic Commitment To Sustainability

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

BNZI

Banzai International Approves Purchase Of Bitcoin Comprising Of 10% Of Corporate Treasury Account

Tenet Healthcare shares are trading lower. The stock may be moving on continued weakness following a Wells Fargo ratings downgrade and price target cut on Monday.

Truist Securities analyst Patrick Scholes maintains Hilton Grand Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HGV#NYSE">HGV</a>) with a Buy and lowers the price target from $52 to $51.

Truist Securities Maintains Buy on Hilton Grand Vacations, Lowers Price Target to $51

Collaboration to Revolutionize Consumer Engagement at Retail Point-of-Sale
BARTLETT, Tenn., Nov. 26, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4311751-1&amp;h=2178492921&amp;u=http%3A%2F%2Fwww.surgepays.com%2F&amp;a=SurgePays%2C+Inc.">SurgePays, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) ("SurgePays" or the "Company"), a technology and telecommunications company, has completed the integration of its&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4311751-1&amp;h=1268366785&amp;u=https%3A%2F%2Fclearline.me%2F&amp;a=ClearLine">ClearLine</a>&nbsp;point-of-sale marketing platform with <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4311751-1&amp;h=2856196004&amp;u=https%3A%2F%2Fwww.pax.us%2F&amp;a=PAX+Technology">PAX Technology</a>'s lineup of smart payment terminals.

SURG

SurgePays Integrates Its ClearLine Marketing Platform With PAX Smart Payment Terminals, Collaboration To Revolutionize Consumer Engagement At Retail Point-Of-Sale

Truist Securities analyst Neal Dingmann maintains EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) with a Hold and raises the price target from $32 to $41.

Truist Securities Maintains Hold on EQT, Raises Price Target to $41

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.astronics.com%2F&amp;esheet=54158326&amp;newsitemid=20241126969679&amp;lan=en-US&amp;anchor=Astronics+Corporation&amp;index=1&amp;md5=015f1afd25598de783032dd05ac5024a">Astronics Corporation</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRO#NASDAQ">ATRO</a>) ("Astronics" or the "Company") today announced the pricing of $150 million aggregate principal amount of 5.500% convertible senior notes due 2030 (the "Notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Astronics also granted the initial purchasers of the Notes an option to purchase up to an additional $15 million aggregate principal amount of the Notes, for settlement within a 13-day period beginning on, and including, the first date on which the Notes are issued. The offering of the Notes is expected to close on December 3, 2024, subject to customary closing conditions.
The Notes will be Astronics' senior unsecured obligations. The Notes will mature on March 15, 2030, unless earlier converted, redeemed or repurchased. The Notes will bear interest at a rate of 5.500% per year, payable semi-annually in arrears on March 15 and September 15 of each year, beginning on March 15, 2025.

Offerings

ATRO

Astronics Corp Announces The Pricing Of $150M Aggregate Principal Amount Of 5.500% Convertible Senior Notes Due 2030

NANO Nuclear Energy And Everstar Announce Outcome Of Three-Month Pilot Project, Say It Has Produced An 'advanced AI-driven compliance solution'

SLNO

Soleno Therapeutics Announces FDA Extension Of Review Period For DCCR Extended-Release Tablets In Prader-Willi Syndrome, New PDUFA Target Action Date Is Mar. 27, 2025

Next-generation satellite equipped with advanced sensor suite and AI-driven data capabilities to deliver critical insights from orbit and expand Sidus Space's on-orbit presence.
Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) (the "Company" or "Sidus"), an innovative, agile space mission enabler, announced the successful completion of the launch processing of LizzieSat&#x2122;-2 at the Astrotech Space Operations facility at Vandenberg Space Force Base in California. LizzieSat&#x2122;-2 has been turned over to SpaceX and is ready for launch on the Bandwagon-2 rideshare mission, which is targeted for no earlier than December of 2024.
LizzieSat&#x2122;-2 was designed and manufactured at Sidus Space's state-of-the-art facility on Florida's Space Coast. The satellite is equipped with an advanced sensor suite that includes AIS, multi-spectral methane detection, and high-resolution visual spectrum sensors, as well as the HEO Holmes Imager, provided by HEO (USA), a subsidiary of Australian-based HEO. The Holmes Imager is a cutting-edge technology that powers HEO Inspect, an in-orbit satellite inspection platform designed for non-Earth imaging (NEI) and the precise characterization of space objects. LizzieSat&#x2122;-2 will provide data through a monthly subscription contract for HEO, further demonstrating Sidus Space's role as a leading provider of multi-mission space-based data solutions.
Leveraging Sidus' proprietary FeatherEdge&#x2122; AI processor, LizzieSat&#x2122;-2 will enable on-orbit data processing for actionable insights, supporting applications such as Space Situational Awareness (SSA), non-Earth Imaging, maritime monitoring, environmental assessments and disaster response.

SIDU

Sidus Space Announces LizzieSat-2 Ready For Launch; Has Been Turned Over To SpaceX And Is Ready For Launch On The Bandwagon-2 Rideshare Mission, Which Is Targeted For No Earlier Than December Of 2024

BTIG raised the firm's price target on Revolve Group (RVLV) to $35 from $30 and keeps a Buy rating on the shares after its Q3 earnings beat. The co...

Revolve Group price target raised to $35 from $30 at BTIG

Piper Sandler analyst Anna Andreeva maintained a Buy rating on Revolve Group (RVLV – Research Report) today and set a price target of $35.00. The c...

Piper Sandler Keeps Their Buy Rating on Revolve Group (RVLV)

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on O'Reilly Auto (ORLY – Research Report), Res...

Analysts Offer Insights on Consumer Cyclical Companies: O'Reilly Auto (ORLY), Restaurant Brands International (QSR) and Revolve Group (RVLV)

In a report released today, Michael Binetti from Evercore ISI maintained a Hold rating on Revolve Group (RVLV – Research Report), with a price targ...

Evercore ISI Sticks to Its Hold Rating for Revolve Group (RVLV)

UBS raised the firm's price target on Revolve Group (RVLV) to $30 from $25 and keeps a Neutral rating on the shares following the "solid" quarter. ...

Revolve Group price target raised to $30 from $25 at UBS

Bank of America Securities analyst Lorraine Hutchinson maintained a Sell rating on Revolve Group (RVLV – Research Report) today. The company's shar...

Bank of America Securities Keeps Their Sell Rating on Revolve Group (RVLV)

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Trump Media (DJT) jumps after Donald T...

Trump Media, broader market surge after Trump wins election: Morning Buzz

Revolve Group (RVLV) is up 23.0%, or $5.98 to $32.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...

Revolve Group rises 23.0%

Wall Street is reacting positively to Donald Trump's victory in the presidential election, with Republicans also securing Senate control.

Stocks Nab Post-Election Record Highs

In a report released today, Janine Stichter from BTIG maintained a Buy rating on Revolve Group (RVLV – Research Report), with a price target of $35...

BTIG Sticks to Its Buy Rating for Revolve Group (RVLV)

AAPL

AVDX

CBOE

CELH

CTKB

EXAS

FIVE

HNDAF

HNHAF

HNHPF

IRBT

NOVA

NTDOF

NTDOY

ORLY

PACS

PLNT

RVLV

SMCI

SNOW

STLA

TEVA

TNGX

TRMB

Press Releases

REVOLVE GROUP, INC. ACQUIRES A MAJORITY STAKE IN FRENCH COUTURE HOUSE ALEXANDRE VAUTHIER

Revolve Group, Inc. to Announce Second Quarter 2024 Financial Results on August 6, 2024

Earnings

Revolve Group Announces Second Quarter 2024 Financial Results

Revolve Group, Inc. to Present at the Piper Sandler Growth Frontiers Conference on Tuesday, September 10

REVOLVE ANNOUNCES RENOWNED K-POP ARTIST, JEON SOMI, AS GLOBAL BRAND AMBASSADOR

Revolve Group, Inc. to Announce Third Quarter 2024 Financial Results on November 5, 2024

Entertainment

REVOLVE AND MUUS COLLECTIVE LAUNCH MOBILE FASHION GAME, BELLEMINT IN THE U.S.

REVOLVE GROUP ANNOUNCES EXCLUSIVE HOLIDAY SHOP AT THE GROVE IN LOS ANGELES

Revolve Group Announces Third Quarter 2024 Financial Results

REVOLVE AND LEAGUE ONE VOLLEYBALL ANNOUNCE PARTNERSHIP TO REDEFINE SPORTS AND FASHION FOR WOMEN

American Eagle Outfitters, Inc. Common Stock

American Eagle Outfitters

a.k.a. Brands Holding

Abercrombie & Fitch

Buckle

Boot Barn Holdings

Burlington Stores

Caleres

Torrid Holdings

Designer Brands Inc. Class A Common Stock

Designer Brands

Foot Locker

Genesco

Guess

J.Jill

Lands' End

MYT Netherlands Parent B.V. American Depositary Shares, each representing one Ordinary Share

Comments

Revolve Gr

ニュース

最新ニュース Revolve Gr (NYSE:RVLV) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル